(Q44572475)

4 December 2017

Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms (English)

1 reference

4 December 2017

0 references

3

1 reference

4 December 2017

Andres D Ramirez

1

1 reference

PubMed ID

12954356

4 December 2017

Stephen K-F Wong

series ordinal

2

1 reference

PubMed ID

12954356

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

European Journal of Pharmacology

4 December 2017

1 reference

4 December 2017

475

1 reference

4 December 2017

1-3

1 reference

4 December 2017

29-35

1 reference

Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Neuroprotective effects of pramipexole in young and aged MPTP-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Complex I and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Neurotoxins, parkinsonism and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Differential distribution of D3 dopamine receptors in the brains of several mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902087-9

10.1016/S0014-2999(03)02087-9

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

12954356